Xin Gong

No ORCID on file · 4 papers in corpus · active 2014-2023

Study types

  • article 4

Condition tags

  • endometriosis 3
article 2023
Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway
Molecular medicine reports ·doi:10.3892/mmr.2023.13108

Endometriosis (EMs) is a common gynecological disorder characterized by abnormal growth of the endometrial stroma and glands outside the uterus. Tanshinone IIA, the active component of Chinese medicine Danshen (Salvia miltiorrhiza Bge.), ha…

article 2019
Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting
Life sciences ·doi:10.1016/j.lfs.2019.117085
article 2017
Effect of Hua Yu Xiao Zheng decoction on the expression levels of vascular endothelial growth factor and angiopoietin‑2 in rats with endometriosis
Experimental and therapeutic medicine ·doi:10.3892/etm.2017.5280

The aims of the present study were to investigate the effects of a traditional Chinese medicine, Hua Yu Xiao Zheng (HYXZ) decoction, on surgically induced endometriosis in a rat model and to determine the possible underlying regulatory mech…

article 2014
Effect of Danzhi decoction on expression of angiogenesis factors in patients with sequelae of pelvic inflammatory disease
·doi:10.1016/s1995-7645(14)60173-5

OBJECTIVE: To investigate the effects of traditional Chinese medicine, Danzhi decoction, on the expression angiogenesis factors in human endometrial cells during the sequelae of pelvic inflammatory disease (SPID) and explore the role of Dan…